BTAX — Stock activity · TradeandTell
BTAX BTAX $0.00 +$0.00 (+0.00%) prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$0.00 – $0.00
0% from low
Borrow rate
0.25%
Easy to borrow
Financials Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
Income Balance sheet Cash flow
2020 2021 2022 2023 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 — — — — $126.3K $152.7K $14.2K $473.5K −$887.0K −$738.2K −$1.2M −$1.5M $2.1M $3.8M −$3.4M −$2.1M $1.6M $3.6M −$3.5M −$2.4M — — — — 0.11 0.38 -0.10 -0.03
Annual figures · source: Financial Modeling Prep
Peer comparison Symbol Price Today Mkt cap P/E BTAX Biostax Corp. $0.00 +0.00% $7871 — ARDS Aridis Pharmaceuticals, Inc. $0.00 -75.00% $4457 — EVLO Evelo Biosciences, Inc. $0.00 +0.00% $1898 — GSRX GSRX Industries Inc. $0.00 +0.00% $8180 — HSTC HST Global, Inc. $0.70 +0.00%
Held by traders on TradeandTell No one on the platform currently holds BTAX.
Super investors & insiders Institutions holding (13F)
No tracked institution reports a position in BTAX as of their last filing.
Insider activity (SEC Form 4)
Stock splits Execution date Ratio 2012-02-27 1-for-1000reverse
Recent trades on TradeandTell No one on the platform has traded BTAX yet.
Report a bug INFIQ Infinity Pharmaceuticals, Inc. $0.00 +0.00% $9076 —
PANC Panacos Pharmaceuticals, Inc. $0.00 +0.00% $5367 —
Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$BTAX chatter on StockTwits $BTAX Biostax Announces a Director Appointment of Influential Business Leader Craig Suro
Article Available on StockTitan Website.
View on StockTwits ↗ $BTAX Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors
https://www.stocktitan.net/news/BTAX/biostax-announces-the-appointment-of-ms-mary-clay-caperton-to-its-smz0dqrkfiqb.html
View on StockTwits ↗ $BTAX Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment
https://www.stocktitan.net/news/BTAX/biostax-announces-finra-approval-for-name-and-ticker-symbol-change-xhknenqfbgbt.html
View on StockTwits ↗ Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
